Michael A. Egan

2.8k citations

41 papers · 1.8k indexed · h-index 25

Impact in

Virology top 0.5%
- HIV Research and Treatment
Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in ⓘ

Virology 25
- HIV Research and Treatment 24
Immunology 20
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 10

Co-authors: Robert F. Siliciano (6 shared papers)John H. Eldridge (22 shared papers)Zimra R. Israel (8 shared papers)Shakuntala Megati (9 shared papers)Jörn E. Schmitz (4 shared papers)Norman L. Letvin (4 shared papers)Marcelo J. Kuroda (4 shared papers)George N. Pavlakis (8 shared papers)
Journals: Vaccine (10 papers)Journal of Virology (9 papers)AIDS Research and Human Retroviruses (4 papers)The Journal of Infectious Diseases (4 papers)PLoS ONE (2 papers)
Partner nations: United States Canada Belgium

In The Last Decade

Michael A. Egan

40 papers receiving 1.7k citations

Peers

Countries citing papers authored by Michael A. Egan

Since Specialization

Citations

This map shows the geographic impact of Michael A. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Egan more than expected).

Fields of papers citing papers by Michael A. Egan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Egan. The network helps show where Michael A. Egan may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael A. Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael A. Egan Line = papers co-authored together Michael A. Egan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques Journal of Virology ·Amara Luckay, Maninder K. Sidhu, Rune Kjeken, Shakuntala Megati, Siew-Yen Chong, Vidia Roopchand, Dorys Garcia-Hand, Rashed Abdullah, Ralph P. Braun, David C. Montefiori, Margherita Rosati, Barbara K. Felber, George N. Pavlakis, Iacob Mathiesen, Zimra R. Israel, John H. Eldridge, Michael A. Egan	2007	154
2	The Human Immunodeficiency Virus Type 1gagGene Encodes an Internal Ribosome Entry Site Journal of Virology ·Christopher B. Buck, Xue-Fei Shen, Michael A. Egan, Theodore C. Pierson, Christopher M. Walker, Robert F. Siliciano	2001	140
3	Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys Journal of Virology ·Dan H. Barouch, Jennifer Kunstman, Jennifer Glowczwskie, Kevin Kunstman, Michael A. Egan, Fred W. Peyerl, Sampa Santra, Marcelo J. Kuroda, Jörn E. Schmitz, Kristin Beaudry, Georgia R. Krivulka, Michelle A. Lifton, Darci A. Gorgone, Steven M. Wolinsky, Norman L. Letvin	2003	130
4	Simian Immunodeficiency Virus (SIV)gagDNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection Journal of Virology ·Michael A. Egan, William A. Charini, Marcelo J. Kuroda, Jörn E. Schmitz, Paul Rácz, Klara Tenner‐Racz, Kelledy Manson, Michael S. Wyand, Michelle A. Lifton, Christie E. Nickerson, Tong‐Ming Fu, John W. Shiver, Norman L. Letvin	2000	120
5	Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein Journal of Virology ·Michael A. Egan, L M Carruth, J F Rowell, Xinyao Yu, Robert F. Siliciano	1996	115
6	Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env Gene The Journal of Infectious Diseases ·Michael A. Egan, William A. Pavlat, J. Tartaglia, Enzo Paoletti, Kent J. Weinhold, M L Clements, Robert F. Siliciano	1995	84
7	Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV89.6P challenge in rhesus macaques Vaccine ·Siew-Yen Chong, Michael A. Egan, Michele A. Kutzler, Shakuntala Megati, Amjed Masood, Vidia Roopchard, Dorys Garcia-Hand, David C. Montefiori, Jorge Quiroz, Margherita Rosati, Eva B. Schadeck, Jean Boyer, George N. Pavlakis, David B. Weiner, Maninder K. Sidhu, John H. Eldridge, Zimra R. Israel	2007	79
8	Elicitation of High-Frequency Cytotoxic T-Lymphocyte Responses against both Dominant and Subdominant Simian-Human Immunodeficiency Virus Epitopes by DNA Vaccination of Rhesus Monkeys Journal of Virology ·Dan H. Barouch, Abie Craiu, Sampa Santra, Michael A. Egan, Jörn E. Schmitz, Marcelo J. Kuroda, Tong‐Ming Fu, Jae‐Hwan Nam, Linda S. Wyatt, Michelle A. Lifton, Georgia R. Krivulka, Christine E. Nickerson, Carol I. Lord, Bernard Moss, Mark G. Lewis, Vanessa M. Hirsch, John W. Shiver, Norman L. Letvin	2001	73
9	Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus Nature ·Chad E. Mire, Demetrius Matassov, Joan B. Geisbert, Theresa Latham, Krystle N. Agans, Rong Xu, Ayuko Ota‐Setlik, Michael A. Egan, Karla A. Fenton, David K. Clarke, John H. Eldridge, Thomas W. Geisbert	2015	67
10	A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques Vaccine ·Eva B. Schadeck, Maninder K. Sidhu, Michael A. Egan, Siew-Yen Chong, Priscilla Piacente, Amjed Masood, Dorys Garcia-Hand, Sarah Cappello, Vidia Roopchand, Shakuntala Megati, Jorge Quiroz, Jean Boyer, Barbara K. Felber, George N. Pavlakis, David B. Weiner, John H. Eldridge, Zimra R. Israel	2005	61
11	Use of Major Histocompatibility Complex Class I/Peptide/β2M Tetramers To Quantitate CD8⁺Cytotoxic T Lymphocytes Specific for Dominant and Nondominant Viral Epitopes in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys Journal of Virology ·Michael A. Egan, Marcelo J. Kuroda, Gérald Voss, Jörn E. Schmitz, William A. Charini, Carol I. Lord, Meryl A. Forman, Norman L. Letvin	1999	61
12	Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector Springer Seminars in Immunopathology ·David K. Clarke, David Cooper, Michael A. Egan, R. Michael Hendry, Christopher L. Parks, Stephen A. Udem	2006	57
13	Priming with Plasmid DNAs Expressing Interleukin-12 and Simian Immunodeficiency Virus Gag Enhances the Immunogenicity and Efficacy of an Experimental AIDS Vaccine Based on Recombinant Vesicular Stomatitis Virus AIDS Research and Human Retroviruses ·Michael A. Egan, Siew Yen Chong, Shakuntala Megati, David C. Montefiori, Nina F. Rose, Jean Boyer, Maninder K. Sidhu, Jorge Quiroz, Margherita Rosati, Eva B. Schadeck, George N. Pavlakis, David B. Weiner, John K. Rose, Zimra R. Israel, Stephen A. Udem, John H. Eldridge	2005	56
14	Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines Vaccine ·Rong Xu, Shakuntala Megati, Vidia Roopchand, Amara Luckay, Amjed Masood, Dorys Garcia-Hand, Margherita Rosati, David B. Weiner, Barbara K. Felber, George N. Pavlakis, Maninder K. Sidhu, John H. Eldridge, Michael A. Egan	2008	54
15	Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial Vaccine ·Paul Spearman, Spyros A. Kalams, Marnie Elizaga, Barbara Metch, Ya-Lin Chiu, Mary Allen, Kent J. Weinhold, Guido Ferrari, Scott Parker, M. Juliana McElrath, Sharon E. Frey, Jonathan D. Fuchs, Michael C. Keefer, Michael D. Lubeck, Michael A. Egan, Ralph P. Braun, John H. Eldridge, Barton F. Haynes, Lawrence Corey	2008	49
16	A Novel Method for Detection and ex Vivo Expansion of HIV Type 1-Specific Cytolytic T Lymphocytes AIDS Research and Human Retroviruses ·Michel Lubaki, Michael A. Egan, Robert F. Siliciano, Kent J. Weinhold, Robert C. Bollinger	1994	43
17	Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial PLoS ONE ·Marnie Elizaga, Shuying S. Li, Nidhi Kochar, Gregory J. Wilson, Mary Allen, Hong‐Van Tieu, Ian Frank, Magdalena E. Sobieszczyk, Kristen W. Cohen, Brittany Sanchez, Theresa Latham, David K. Clarke, Michael A. Egan, John H. Eldridge, Drew Hannaman, Rong Xu, Ayuko Ota‐Setlik, M. Juliana McElrath, Christine M. Hay, (unknown)	2018	40
18	Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus The Journal of Infectious Diseases ·Demetrius Matassov, Andrea Marzi, Terri Latham, Rong Xu, Ayuko Ota‐Setlik, Friederike Feldmann, Joan B. Geisbert, Chad E. Mire, Stefan Hamm, Becky Nowak, Michael A. Egan, Thomas W. Geisbert, John H. Eldridge, Heinz Feldmann, David K. Clarke	2015	39
19	A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques Vaccine ·Michael A. Egan, Siew Yen Chong, Michael Hagen, Shakuntala Megati, Eva B. Schadeck, Priscilla Piacente, Benjiang Ma, David C. Montefiori, Barton F. Haynes, Zimra R. Israel, John H. Eldridge, Herman F. Staats	2004	38
20	Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge Journal of Virology ·Demetrius Matassov, Chad E. Mire, Theresa Latham, Joan B. Geisbert, Rong Xu, Ayuko Ota‐Setlik, Krystle N. Agans, Dean J. Kobs, Morgan Q. S. Wendling, Amanda Burnaugh, Thomas L. Rudge, Carol L. Sabourin, Michael A. Egan, David K. Clarke, Thomas W. Geisbert, John H. Eldridge	2017	35

About Michael A. Egan

Michael A. Egan is a scholar working on Virology, Immunology, Infectious Diseases, Epidemiology and Molecular Biology, having authored 41 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (24 papers), Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (10 papers), Viral Infections and Outbreaks Research (9 papers), Virology and Viral Diseases (7 papers), Viral Infections and Vectors (6 papers), Transgenic Plants and Applications (5 papers) and Herpesvirus Infections and Treatments (5 papers). The work is most often cited by research in Virology (883 citations), Immunology (850 citations), Infectious Diseases (608 citations), Epidemiology (559 citations) and Biotechnology (101 citations). Michael A. Egan has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Robert F. Siliciano, John H. Eldridge, Zimra R. Israel, Shakuntala Megati, Jörn E. Schmitz, Norman L. Letvin, Marcelo J. Kuroda, George N. Pavlakis, Maninder K. Sidhu and Margherita Rosati. Their work appears in journals such as Vaccine, Journal of Virology, AIDS Research and Human Retroviruses, The Journal of Infectious Diseases and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact